ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,803, issued on June 17, was assigned to Cura Therapeutics Inc. (Montreal).
"Method of reducing or treating fibrosis by administering an interleukin-2/TGF-beta receptor fusion polypeptide" was invented by Claudia Ania Penafuerte Diaz (Montreal).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGFBeta ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of treating and/or preventing pathogenic infections."
The patent was filed on April 28, 2023, under Application No. 18/309,450.
*For...